ASCO 2020 | DARS study: speech and language therapy

Justin Roe, BA(Hons), Dip THP, PG Dip, MSc, PhD, FRCSLT, of the Royal Marsden NHS Foundation Trust, London, UK, highlights the importance of speech and language therapy in the phase III DARS study, evaluating dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in head and neck cancer in order to improve swallowing after treament.This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).